Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Bioharvest Sciences Inc (CSE: BHSC )

6.750 UNCHANGED
Official Closing Price Updated: 3:46 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 993
Open 6.750
Bid (Size) 6.500 (100)
Ask (Size) 7.100 (100)
Prev. Close 6.750
Today's Range 6.750 - 6.750
52wk Range 0.1600 - 9.200
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
BioHarvest Sciences Announces Record Preliminary Third Quarter 2024 Financial Results
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - October 23, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or... 
Via Newsfile
BioHarvest Sciences to Participate in LD Micro Main Event XVII Conference on October 30, 2024
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - October 16, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or... 
Via Newsfile

Performance

YTD
+3114.29%
+3114.29%
1 Month
-11.18%
-11.18%
3 Month
-14.56%
-14.56%
6 Month
+2712.50%
+2712.50%
1 Year
+3990.91%
+3990.91%

More News

Read More
BioHarvest Sciences Reports Director's Ongoing Key Role Following Resignation from Board
Via Newsfile
iAccess Alpha's Buyside Best Ideas Virtual Fall Conference September 24-25, 2024
Via ACCESSWIRE
BioHarvest Sciences to Participate in iAccess Alpha Buyside Best Ideas Conference on September 24-25, 2024
Via Newsfile
BioHarvest Sciences to Present at H.C. Wainwright 26th Annual Global Investment Conference
Via Newsfile
BioHarvest Sciences Reports Record Second Quarter 2024 Financial Results
Via Newsfile
BioHarvest Sciences Surpasses USD $1.0 Million in Cumulative Direct Sales of Coffee with VINIA Inside
Via Newsfile
BioHarvest Sciences to Host Second Quarter 2024 Corporate Update Call on August 29, 2024, at 2:30 p.m. Eastern Time
Via Newsfile
BioHarvest Sciences Announces Closing of USD $4,329,982 in First Tranche of Private Placement and Conversion of Debt Notes
Via Newsfile
BioHarvest Sciences to Present at Noble Capital Markets Virtual Equity Conference on June 27, 2024
Via Newsfile
BioHarvest Sciences Announces a Private Placement of up to USD $5 Million and Conversion of Debt Notes
Via Newsfile
BioHarvest Sciences to Present at Sidoti Small-Cap Virtual Investor Conference on June 13, 2024
Via Newsfile
BioHarvest Sciences Announces Record $2 Million Monthly Sales
Via Newsfile
BioHarvest Sciences Reports First Quarter 2024 Financial Results
Via Newsfile
BioHarvest Sciences to Host Corporate Update Call May 2 at 2:30 P.M. Eastern Time
Via Newsfile
BioHarvest Sciences Reports Fourth Quarter and Full Year 2023 Financial Results
Via Newsfile
BioHarvest Sciences Announces New Campus for Botanical Synthesis CDMO and Expansion of Manufacturing Capacity
Via Newsfile
BioHarvest Sciences Appoints Anna Tenstam as VP of Business Development, Cosmeceuticals and Injectables
Via Newsfile
Benzinga's 2024 Virtual Healthcare: What's Next In Health?
Via Benzinga
BioHarvest Sciences to Participate in Benzinga Virtual Healthcare Summit 2024 on March 20, 2024
Via Newsfile
Topics Artificial Intelligence
Exposures Artificial Intelligence
BioHarvest Sciences Announces New Strategic Hires for CDMO Services Business Unit
Via Newsfile
RETRANSMISSION: iAccess Alpha's Buyside Best Ideas Spring Virtual Conference March 12th and 13th, 2024
Via ACCESSWIRE
BioHarvest Sciences to Participate in iAccess Alpha Buyside Best Ideas Conference on March 12-13, 2024
Via Newsfile
BioHarvest Sciences to Host Corporate Update Discussing Launch of CDMO Business Unit on March 13 at 2:30 p.m. Eastern Time
Via Newsfile
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.